Tsukuba, Japan

Tomohisa Ninomiya

This inventor holds 2 USPTO granted patents. Top assignee: Alchemedicine, Inc.. Active years: 2025-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tomohisa Ninomiya. Retrieved from https://idiyas.com/inventor/tomohisa-ninomiya-35nkfs6w

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 50.0

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2025-2026

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tomohisa Ninomiya: Innovator in Pharmaceutical Composition

Introduction

Tomohisa Ninomiya is a notable inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that activate aldehyde dehydrogenase 2 (ALDH2). His work has the potential to impact therapeutic and prophylactic treatments.

Latest Patents

Ninomiya holds a patent for a compound, aldehyde dehydrogenase 2 activating agent, pharmaceutical composition, and therapeutic and/or prophylactic drug. This patent includes a compound that exhibits an activation effect on ALDH2, which is crucial for various metabolic processes. The compound is represented by a specific formula, and it includes pharmaceutically acceptable salts or prodrugs.

Career Highlights

He is currently associated with Alchemedicine, Inc., where he continues to innovate in the pharmaceutical sector. His work focuses on enhancing the efficacy of therapeutic agents through the activation of key enzymes.

Collaborations

Ninomiya collaborates with Keigo Tanaka, contributing to advancements in their shared field of research.

Conclusion

Tomohisa Ninomiya's contributions to pharmaceutical innovations, particularly through his patent on ALDH2 activating agents, highlight his role as a significant inventor in the industry. His ongoing work promises to lead to important developments in therapeutic applications.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…